Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicentre study

Articolo

Data di Pubblicazione:

2021

Citazione:

Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicentre study / M. Ferro, M. Marchioni, G. Lucarelli, V.M. Dorin, F. Soria, D. Terracciano, F.A. Mistretta, S. Luzzago, C. Buonerba, F. Cantiello, A. Mari, A. Minervini, A. Veccia, A. Antonelli, G. Musi, R. Hurle, G.M. Busetto, F. Del Giudice, B.I. Chung, F. Berardinelli, S. Perdonà, P. Del Prete, V. Mirone, M. Borghesi, A. Porreca, P. Bove, R. Autorino, N. Crisan, A.R. Abu Farhan, M. Battaglia, P. Ditonno, G.I. Russo, M. Muto, R. Damiano, M. Manfredi, F. Porpiglia, O. De Cobelli, L. Schips. - In: MINERVA UROLOGY AND NEPHROLOGY. - ISSN 2724-6051. - 73:6(2021), pp. 796-802. [10.23736/S0393-2249.20.04076-X]

Abstract:

We aimed to test the hypothesis that the immune-modulatory effect of statins may improve survival outcomes in patients with non-muscle invasive bladder cancer (NMIBC). We focused on a cohort of patients diagnosed with high risk NMIBC, that were treated with intravesical BCG immunotherapy.

Tipologia IRIS:

01 - Articolo su periodico

Keywords:

Urinary bladder neoplasms; Urinary Bladder; Therapeutics; Mortality

Elenco autori: